2nd Annual Risk Management and Pharmacovigilance America Summit 2017
2nd Annual Risk Management and Pharmacovigilance America Summit comes as a continuation of the successful last year´s meeting of the best PV experts on the market. This upcoming October, we will discuss a wide range of topics and areas within drug safety and risk management. As we all know, this field is very important for the whole population and it absolutely requires the constant education and sharing expertise of the best PV professionals. If you want to stay updated with the current Pharmacovigilance issues, do not miss this meeting hold on 24 - 26 October in Boston. Companies such as Astellas, GSK, Merck, Janssen, CSL Behring, Sanofi Pasteur, Otsuka and many more will share case studies and their opinions on topics such as Risk Minimization, Social listening, Outsourcing of Pharmacovigilance, Data Management and Data Mining, RMPs update, function of the Safety Management Teams, New technologies in PV and many others.
Co - Located With |
 |
Key SpeakersMilbor D'Silva Vice President, Head of Safety Science & Site Head for VP Pharmacovigilance Astellas Pharma Global Development Susan Welsh Chief Safety Officer CSL Behring Harry Seifert GlaxoSmithKline Vaccines
Annie Tougas Associate Director, Pharmacovigilance & Medical Information Otsuka Canada Pharmaceutical Inc. Ann Straus AVP CSRM Merck |
Key topics
|
Who Should attendMembers of board, C-level, Senior Vice Presidents, Vice Presidents, Directors and Heads of departments from pharmaceutical involved in: |
|
|
|
A. The Risk Management and Pharmacovigilance America Summit will be a great opportunity to meet the worldwide experts in the drug safety field. After our successful PV and RM meetings in Europe, we are moving to another continent and you have the chance to be part of it. In October, Boston will be the place, where the top experts from companies such as Merck, Pfizer, Amgen, Novartis, Genentech, Gilead Sciences, Takeda and others, will speak about interesting case studies from different areas within the drug safety. You will get the best advices on how to implement new legislation into the real world settings, how to deal with increasing volumes of ICSRs, how to improve the pharmacovigilance and risk management procedures in your company, Benefit-Risk Evaluations and frameworks, signal detection, the future of pharmacovigilance, comparison of the US, EU and Latin America pharmacovigilance processes, etc. You will also find many networking and discussing opportunities there, where you will be able to exchange practical insights with other participants and pharmacovigilance/risk management experts. Save the date from 18th to 20th October and do not miss any news from the pharmacovigilance world in 2016.